Drugs / HL-003
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06867393 Comparator | Feb → Aug 2025 overdue | — | Shanghai Kechow Pharma, Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HL-003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06867393 ↗ |
| Route | Oral | “Single and Multiple Oral Doses” NCT06867393 ↗ |